Griffin Securities Sees More Countries Approving Intrexon's (XON) OX513A Amid Zika Pandemic

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Griffin Securities Sees More Countries Approving Intrexon's (XON) OX513A Amid Zika Pandemic

Fibrocell Highlights Recent Pipeline Accomplishments

January 27, 2016 8:01 AM EST

Patient Dosing in Phase II Trial of azficel-T for Chronic Dysphonia Completed Preclinical Toxicology Study for FCX-007 InitiatedPositive POC Data Shows FCX-013 Reduces Dermal Thickness of Fibrotic Tissue

EXTON, Pa., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ: FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs, today highlighted several recent accomplishments related to the continued advancement of the companys pipeline.

Recently, Fibrocell has made significant progress across our pipeline of personalized biologics, positioning the company to achieve... More